Dublin, Jan. 09, 2025 (GLOBE NEWSWIRE) -- The "Genomic Biomarkers Market Report 2024" has been added to ResearchAndMarkets.com's offering. The genomic biomarkers market size has grown rapidly in ...

Use of pathological response versus RECIST assessment in predicting relapse-free survival following neoadjuvant immunotherapy for hepatocellular carcinoma. Expanded biomarker analysis of an ...

Researchers from Tel Aviv Sourasky Medical Center presented data from a study that aimed to investigate the genetic ...

Machine learning, artificial intelligence techniques and analysis of large datasets have helped researchers discover proteins ...

(RTTNews) - Adial Pharmaceuticals, Inc. (ADIL), Wednesday revealed positive results from its pharmacokinetics study of AD04 for the treatment of Alcohol Use Disorder in patients with a 5-HT3 genomic ...

The genomic urine testing industry in the United States is predicted to reach USD 66.3 million by 2033, increasing at a 4.9% ...

Neurological biomarkers industry is projected to witness a CAGR of 10.9% during the period 2025-2034. This growth can be ...

Machine learning and artificial intelligence (AI) techniques and analysis of large datasets have helped University of Birmingham researchers to discover proteins that have strong predictive potential ...

Adial Pharmaceuticals has completed a pharmacokinetics study of its investigational drug AD04, aimed at treating Alcohol Use Disorder (AUD) in patients with a specific genomic biomarker.